Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quality of life and quality of care for patients with gout.

Literature DB >> 19296889

Quality of life and quality of care for patients with gout.

Abstract

Significant pain, activity limitation, and disability in patients with acute and chronic gouty arthritis lower health-related quality of life. Although many effective therapies are available for gouty arthritis, medication errors are common. One goal of therapy is to reduce the frequency of gout flares by lowering serum uric acid. Further, evidence suggests that the quality of care provided to patients with gout may also impact health-related quality of life. This article reviews evidence concerning quality of care and quality of life for patients with gout.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19296889 PMCID： PMC3855300 DOI： 10.1007/s11926-009-0022-4

Source DB: PubMed Journal: Curr Rheumatol Rep ISSN： 1523-3774 Impact factor: 4.592

27 in total

1. How is gout managed in primary care? A review of current practice and proposed guidelines.

Authors: B Pal; M Foxall; T Dysart; F Carey; M Whittaker
Journal: Clin Rheumatol Date: 2000 Impact factor: 2.980

2. Is gout associated with reduced quality of life? A case-control study.

Authors: E Roddy; W Zhang; M Doherty
Journal: Rheumatology (Oxford) Date: 2007-06-24 Impact factor: 7.580

3. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.

Authors: J A Singh; V Strand
Journal: Ann Rheum Dis Date: 2008-01-04 Impact factor: 19.103

4. A survey of the management of gout in primary care.

Authors: D Owens; B Whelan; G McCarthy
Journal: Ir Med J Date: 2008-05

5. Appropriateness of medication selection for older persons in an urban academic emergency department.

Authors: M H Chin; L C Wang; L Jin; R Mulliken; J Walter; D C Hayley; T G Karrison; M P Nerney; A Miller; P D Friedmann
Journal: Acad Emerg Med Date: 1999-12 Impact factor: 3.451

6. Evaluation of an instrument assessing influence of Gout on health-related quality of life.

Authors: Jan D Hirsch; Susan J Lee; Robert Terkeltaub; Dinesh Khanna; Jasvinder Singh; Andrew Sarkin; Jodi Harvey; Arthur Kavanaugh
Journal: J Rheumatol Date: 2008-10-15 Impact factor: 4.666

7. Opportunities for improving medication use and monitoring in gout.

Authors: J A Singh; J S Hodges; S M Asch
Journal: Ann Rheum Dis Date: 2008-08-13 Impact factor: 19.103

8. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.

Authors: Edward Roddy; Weiya Zhang; Michael Doherty
Journal: Ann Rheum Dis Date: 2007-05-15 Impact factor: 19.103

9. Colchicine prescribing and safety monitoring in patients with gout.

Authors: Jason Ly; Peter Gow; Nicola Dalbeth
Journal: N Z Med J Date: 2007-11-09

10. The disutility of chronic gout.

Authors: Dinesh Khanna; Mansoor Ahmed; Dustin Yontz; Shaari S Ginsburg; Grace S Park; Anthony Leonard; Joel Tsevat
Journal: Qual Life Res Date: 2008-05-24 Impact factor: 4.147

26 in total

1. Patient-reported outcomes in chronic gout: a report from OMERACT 10.

Authors: Jasvinder A Singh; Will J Taylor; Lee S Simon; Puja P Khanna; Lisa K Stamp; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Michael A Becker; Patricia A MacDonald; Omar Dabbous; Vibeke Strand; Nicola D Dalbeth; Daniel Aletaha; N Lawrence Edwards; H Ralph Schumacher
Journal: J Rheumatol Date: 2011-07 Impact factor: 4.666

2. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.

Authors: Janet W Maynard; Mara A McAdams-DeMarco; Andrew Law; Linda Kao; Allan C Gelber; Josef Coresh; Alan N Baer
Journal: Am J Epidemiol Date: 2013-12-13 Impact factor: 4.897

3. Rheumatologists' perception of systemic lupus erythematosus quality indicators: significant interest and perceived barriers.

Authors: Carolyn Casey; Cecilia P Chung; Leslie J Crofford; April Barnado
Journal: Clin Rheumatol Date: 2016-11-22 Impact factor: 2.980

4. Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.

Authors: Rosane M S dos Santos; Sara M Oliveira; Cássia R Silva; Carin Hoffmeister; Juliano Ferreira; Jamil Assreuy
Journal: Inflamm Res Date: 2013-03-30 Impact factor: 4.575

5. Gout treatment: survey of Brazilian rheumatology residents.

Authors: Rodrigo Balbino Chaves Amorim; Ana Beatriz Vargas-Santos; Leticia Rocha Pereira; Evandro Silva Freire Coutinho; Geraldo da Rocha Castelar-Pinheiro
Journal: Clin Rheumatol Date: 2017-01-19 Impact factor: 2.980

6. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.

Authors: Michael Chen-Xu; Chio Yokose; Sharan K Rai; Michael H Pillinger; Hyon K Choi
Journal: Arthritis Rheumatol Date: 2019-04-15 Impact factor: 10.995